Ablation of the retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions

Genes and Development

Volumn 14, Issue 23, 2000, Pages 3051-3064

  Dannenberg, J H ^a   Van Rossum, A ^a   Schuijff, L ^a   Te Riele, H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cell cycle control; Cell turnover; p107; p130; Pocket proteins; Rb

Indexed keywords

POCKET PROTEIN; PROTEIN P107; PROTEIN P130; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL GROWTH; CELL IMMORTALIZATION; CELL METABOLISM; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; G1 PHASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; STEM CELLS; TERATOCARCINOMA; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0033635597     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.847700     Document Type: Article

References (90)

1. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts
2. p14ARF links the tumour suppressors RB and p53
3. E2F: A nodal point in cell cycle regulation
4. p27kip-independent cell cycle regulation by MYC
5. Radiation-induced cell cycle arrest compromised by p21 deficiency
6. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells
7. The biology of replicative senescence
8. p16(INK4A) and p19(ARF) act in overlapping pathways in cellular immortalization
9. Requirement for a functional Rb-1 gene in murine development
10. Shared role of the pRB-related p130 and p107 proteins in limb development
11. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
12. E1A signaling to p53 involves the p19(ARF) tumor suppressor
13. The regulation of E2F by pRB-family proteins
14. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
15. Induction of apoptosis in fibroblasts by c-myc protein
16. Dependence of cyclin E-CDK2 kinase activity on cell anchorage
17. Promoter traps in embyonic stem cells. A genetic screen to identify and mutate developmental genes in mice
18. Oncogenic Ras induces p19(ARF) and growth arrest in mouse embryo fibroblasts lacking p21(Cip)1 and p27Kip1 without activating cyclin D-dependent kinases
19. A link between cyclin A expression and adhesion-dependent cell cycle progression
20. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
21. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC
22. pRB plays an essential role in cell cycle arrest induced by DNA damage
23. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine fibroblasts
24. In vitro growth characteristics of embryo fibroblasts isolated of p53-deficient mice
25. The serial cultivation of human diploid cell strains
26. Mediation of c-Myc-induced apoptosis by p53
27. Altered cell cycle kinetics, gene expression and G1 restriction point regulation in Rb-deficient fibroblasts
28. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells
29. Heterozygous Rb-1ΔA20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance
30. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
31. Effects of an Rb mutation in the mouse
32. A cell cycle regulator involved in genesis of many tumor types
33. Tumor suppresion at the mouse INK4a locus mediated by the alternative reading frame product p19arf
34. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
35. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells
36. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
37. Cloning and expression of the Rb-related mouse p130 mRNA
38. Strain-dependent myeloid hyperplasia, growth deficiency and accelerated cell cycle in mine lacking the Rb-related p107 gene
39. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene
40. Inactivation of the retinoblastoma susceptibility gene in human breast cancers
41. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
42. Targeted disruption of p107. Functional overlap between p107 and Rb
43. The retinoblastoma gene family in differentiation and development
44. Cooperating oncogenes converge to regulate cyclin/cdk complexes
45. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
46. Abrogation of oncogene-associated apoptosis allows transformation of p53-deflclent cells
47. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
48. The retinoblastoma gene family: Cousins with overlapping interests
49. p130 is dispensable in peripheral T lymphocytes Evidence for functional compensation by p107 and pRB
50. Sequences and factors required for the F9 embryonal carcinoma stem cell Ela-like activity
51. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
52. Reversible arrest of growth in G1 of an established cell flbroblast line (3T3)
53. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
54. Cyclin-dependent regulation of G1 in mammalian fibroblasts
55. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status
56. p19(ARF) links the tumour suppressor p53 to Ras
57. Murine flbroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras
58. p27Kip, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
59. The Ink4a tumor suppressor gene product, p19(Arf), interacts with MDM2 and neutralizes MDM2's inhibition of p53
60. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
61. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of reducing cell cycle arrest
62. Accumulation of p53 induced by the adenovirus E1A protein requires regions revolved in the stimulation of DNA synthesis
63. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation
64. p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells
65. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice
66. p107 is a suppressor of retinoblastoma development in pRb-deficient mice
67. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts
68. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells
69. Anchorage-dependent transcription of the cyclin A gene
70. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
71. Role of the INK4a locus in tumor suppression and cell mortality
72. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(ink4a)
73. Cancer cell cycles
74. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
75. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs
76. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines
77. Mutation of E2f-1 suppresses apoptosis and inappropiate S phase entry and extends survival of Rb-deficient mouse embryos
78. Distinct roles for cyclin-dependent kinases in cell cycle control
79. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse
80. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1
81. The retinoblastoma protein and cell cycle control
82. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
83. Interaction between the retinoblastoma protein and the oncoprotein MDM2
84. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
85. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16(INK4A), TGFβ, and contact inhibiton
86. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19(ARF) is a candidate for the plasmacytoma susceptibility locus, Pctr1
87. ARF promotes MDM2 degradation and stabilizes p53 ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
88. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging
89. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
90. Schwann cell differentiation